Morgan Stanley Boosts Boston Scientific (NYSE:BSX) Price Target to $92.00
Boston Scientific (NYSE:BSX – Free Report) had its price objective hoisted by Morgan Stanley from $79.00 to $92.00 in a research report released on Monday morning, Benzinga reports. Morgan Stanley currently has an overweight rating on the medical equipment provider’s stock. BSX has been the topic of several other research reports. Evercore ISI lifted their […]
More Stories
Birchcreek Wealth Management LLC Makes New $213,000 Investment in U.S. Bancorp (NYSE:USB)
Birchcreek Wealth Management LLC bought a new position in U.S. Bancorp (NYSE:USB – Free Report) in the third quarter, according...
iShares Core S&P U.S. Growth ETF (NASDAQ:IUSG) Shares Sold by Birchcreek Wealth Management LLC
Birchcreek Wealth Management LLC lowered its stake in iShares Core S&P U.S. Growth ETF (NASDAQ:IUSG – Free Report) by 0.2%...
Archer Investment Corp Buys Shares of 69,397 BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF (NYSEARCA:XSVN)
Archer Investment Corp purchased a new stake in shares of BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF (NYSEARCA:XSVN...
Birchcreek Wealth Management LLC Purchases 25,627 Shares of Dimensional U.S. Small Cap ETF (NYSEARCA:DFAS)
Birchcreek Wealth Management LLC boosted its position in shares of Dimensional U.S. Small Cap ETF (NYSEARCA:DFAS – Free Report) by...
Birchcreek Wealth Management LLC Lowers Holdings in Vanguard Energy ETF (NYSEARCA:VDE)
Birchcreek Wealth Management LLC lowered its position in shares of Vanguard Energy ETF (NYSEARCA:VDE – Free Report) by 1.8% in...
Sonos Target of Unusually High Options Trading (NASDAQ:SONO)
Sonos, Inc. (NASDAQ:SONO – Get Free Report) was the target of unusually large options trading on Thursday. Stock traders bought...